Out-Licenses. (a) Subject to compliance with this Section 5.11, the Seller may enter into an Out-License (but not assign or otherwise convey title to) with a Third Party or enter into an agreement to research, develop or manufacture (each, a “Permitted Licensee”) with respect to all or a portion of the Intellectual Property Rights to develop, manufacture, promote, market, use, sell, offer for sale or import the Product in all or any portion of the world without the Buyer’s prior written consent (any such license, a “Permitted License”).
Out-Licenses. (a) Seller shall not grant to any Third Person any exclusive right or license under the Product IP without the prior written consent of Purchaser, such consent not to be unreasonably withheld, conditioned or delayed.
Out-Licenses. (a) Subject to compliance with this Section 5.12 and Section 5.15 below, Cibus may license or cause its Affiliates to license (but not assign or otherwise transfer title to, except pursuant to Section 10.6) all or a portion of the RTDS Rights to a Third Party (a “Permitted Licensee”) to develop, manufacture, promote, market, use, sell, offer for sale, import or distribute products arising out of the RTDS Rights in all or any portion of the Territory without the Seller Representative’s prior written consent (any such license, a “Permitted License”).
Out-Licenses. (a) Subject to compliance with this Section 5.12, the Seller may license (but not assign or otherwise convey title to, except pursuant to Section 9.6) all or a portion of the Vosaroxin Product Rights to a Third Party (a “Permitted Licensee”) to develop, manufacture, promote, market, use, sell, offer for sale, import or distribute Product(s) in all or any portion of the Territory without the Buyer’s prior written consent (any such license, a “Permitted License”).
Out-Licenses. (a) Subject to Section 4.14 and compliance with this Section 4.12, Seller may license (but not assign or otherwise convey title to, except pursuant to Section 9.3) all or a portion of the Vascepa Product Rights to a Third Person (a “Permitted Licensee”) to research, develop, manufacture, promote, market, use, sell, offer for sale, import or distribute Product(s) in all or any portion of the Territory without the Purchaser’s prior written consent (any such license, a “Permitted License”).
Out-Licenses. Neither the Company nor any of its subsidiaries has transferred ownership of, or granted any exclusive license with respect to, any Company Intellectual Property to any third party (herein "OUT LICENSE"), except where such transfer or license has not had and is not reasonably likely to have, individually or collectively, a Material Adverse Effect.
Out-Licenses. Section 3.11(h) of the Seller Disclosure Schedule lists all Contracts, licenses and agreements to which Seller is a party and under which Seller has granted, licensed or provided any Seller Owned Intellectual Property to third parties (“Out-Licenses”), other than (i) licenses pursuant to which Seller has granted rights to contractors or vendors to use Seller Owned Intellectual Property for the sole benefit of Seller, (ii) non-disclosure agreements, and (iii) nonexclusive licenses or rights granted by Seller to vendors or end users of the Seller Products in the ordinary course of Business of Seller.
Out-Licenses. In the event that Applera and Celera are unable to amend the license agreements with third parties set forth on Section 5.6(d) of the Disclosure Letter (the “Out Licenses”) to add Celera or a Celera Subsidiary as a party thereto or enter into new license agreements with Celera or a Celera Subsidiary, in either case, upon terms that are substantially similar to the terms in such agreements relating to the Celera Business or the Celera Group Assets as are then in effect, then Applera agrees from and after the Redemption Date to pay Celera all royalties, milestone payments and other amounts received pursuant to such Out Licenses relating to the Celera Business or the Celera Group Assets.
Out-Licenses. (a) Subject to compliance with this Section 5.6, the Company may enter into Out-Licenses that are Permitted Licenses without the Investors’ prior written consent. The Company may not enter into any other Out-Licenses without the Investors’ prior written consent.
Out-Licenses. During the term of the Revenue Participation Right:
